Título : Variation in Colonoscopy Performance Measures According to Procedure Indication |
Autor : Mangas-Sanjuan, Carolina Santana, Enrique Cubiella, Joaquín Rodríguez Camacho, Elena Seoane, Agustín Alvarez-Gonzalez, Marco Antonio Suárez, Adolfo Álvarez-García, Verónica González, Natalia Luè, Alberto Cid-Gomez, Lucía Ponce, Marta Bujanda, Luis Portillo, Isabel Pellisé, María Díez-Redondo, Pilar Herraiz, Maite Ono, Akiko Pizarro, Angeles Zapater, Pedro JOVER, RODRIGO |
Editor : AGA Institute |
Departamento: Departamentos de la UMH::Medicina Clínica |
Fecha de publicación: 2020-05 |
URI : https://hdl.handle.net/11000/30889 |
Resumen :
BACKGROUND & AIMS: Most fulfillment and benchmarking information for colonoscopy quality indicators has been obtained from studies of primary screening colonoscopies. We analyzed differences in the fulfillment of colonoscopy quality indicators based on the indication for endoscopy.
METHODS: We performed an observational, multicenter, cross-sectional study of 14,867 patients who
underwent endoscopy procedures for gastrointestinal symptoms (40.3%), a positive result from a fecal immunochemical test (36.0%), postpolypectomy surveillance (15.3%), or primary screening (8.4%), from February 2016 through December 2017 at 14 centers in Spain. We evaluated rates of adequate colon cleansing, cecal intubation, adenoma detection, and colorectal cancer detection, among others. We used findings from primary screening colonoscopies as the reference standard.
RESULTS: Fewer than 90% of patients had adequate bowel preparation; 83.1% of patients with gastrointestinal
symptoms had adequate bowel preparation (odds ratio [OR] compared with patients with primary screening colonoscopies, 0.62; 95% CI, 0.49–0.78) and 85.3% of patients receiving postpolypectomy surveillance had adequate bowel preparation (OR, 0.71; 95% CI, 0.55–0.91). The cecal intubation rate was also lower in patients with gastrointestinal symptoms (93.1%) (OR, 0.34; 95% CI, 0.22–0.52). The adenoma detection rate was higher in patients with a positive result from a fecal immunochemical test (46.4%) (OR, 2.01; 95% CI, 1.71–2.35) and in
patients undergoing postpolypectomy surveillance (48.2%) (OR, 1.41; 95% CI, 1.20–1.67). The highest proportion of patients with colorectal cancer was in the gastrointestinal symptom group (5.1%) (OR, 5.24; 95% CI, 2.30–11.93) and the lowest was in patients undergoing surveillance (0.8%) (OR, 0.83; 95% CI, 0.32–2.14).
CONCLUSIONS: Fulfillment of colonoscopy performance measures varies substantially by indication. Policies
addressing performance measures beyond colonoscopy screening procedures should be developed.
Benchmarking recommendations could be adjusted according to colonoscopy indication.
|
Palabras clave/Materias: Comparison Colon Cancer ADR FIT |
Tipo documento : application/pdf |
Derechos de acceso: info:eu-repo/semantics/closedAccess Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
DOI : https://doi.org/10.1016/j.cgh.2019.08.035 |
Aparece en las colecciones: Artículos Medicina Clínica
|